CDMO
Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-24-CL-08Oct 11, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04Sep 04, 2024
Digitalization
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Michael Sokolov, Ph.D.
DataHow
PAO-08-24-CL-02Aug 26, 2024
IND Enablement
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
Johannes Clemens
Coriolis Pharma
PAO-08-24-CL-07Aug 16, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04Jul 29, 2024
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03Jul 22, 2024
Training
Biotech Training is a Challenge
April Stanley, MS MBA; Koey Keylon
Nice Insight
PAO-06-24-NI-01Jun 11, 2024
Leap-In Transposase
Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform
Wheeler Bio
PAO-06-24-CL-05May 30, 2024
The PHASE Platform
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
Wheeler Bio
PAO-05-24-CL-01May 08, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09Feb 26, 2024
CMC
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
Wheeler Bio
PAO-12-23-CL-04Feb 08, 2024
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
Jiyeon Lee; Hyelyoung Jang
Samsung Biologics
POD-01-24-CL-01Jan 16, 2024
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Junyong Park
Samsung Biologics
PAO-12-23-CL-06Dec 14, 2023
Stem Cell Therapy
Designing A Recipe for Stem Cell Therapy Success
Ben Josey, Ph.D.; Robert Padilla
Corning Life Sciences
PTV-12-23-CL-01Dec 12, 2023
Cell and Gene Therapy
Scaling Cell and Gene Therapy Processes from R&D to Production
Shawn Bates; Antonio Fernandez-Perez, Ph.D.
Corning Life Sciences
PAO-12-23-CL-03Dec 12, 2023
Cell Culture Media
Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients
Chris Wiedel
Nu-Tek BioSciences
PAO-10-23-CL-01Dec 06, 2023
Cell Culture Media
Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products
Thomas Yezzi
Nu-Tek BioSciences
PAO-08-23-CL-05Nov 14, 2023
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01Nov 08, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06Oct 24, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01Oct 05, 2023